Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Harrington

Showing results (141-150 of 197) with videos related to

Pageof 20
Sort By:
British Journal of Cancer|November 25, 2016
Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neckLiam Welsh, Rafal Panek, Angela Riddell, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative diseaseKevin Harrington, Alain Berrier, Martin Robinson, et al.
Molecular Therapy Oncolytics|December 10, 2016
Immunogenicity of self tumor associated proteins is enhanced through protein truncationTim Kottke, Kevin G Shim, Vanesa Alonso-Camino, et al.
BMJ Open|August 9, 2024
Predicting radiotherapy response, Toxicities and quality-of-life related functional outcomes in soft tissue sarcoma of the extremities (PredicT) using dose-volume constraints development: a study protocolRita Simões, Sarah Gulliford, Beatrice Seddon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 16, 2016
The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with 18F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell CarcinomaKee H Wong, Rafal Panek, Liam Welsh, et al.
BMC Medical Research Methodology|July 11, 2022
Methodology for the development of National Multidisciplinary Management Recommendations using a multi-stage meta-consensus initiativeJohn C Hardman, Kevin Harrington, Tom Roques, et al.
Magma (New York, N.Y.)|January 5, 2011
A Bayesian hierarchical model for DCE-MRI to evaluate treatment response in a phase II study in advanced squamous cell carcinoma of the head and neckBrandon Whitcher, Volker J Schmid, David J Collins, et al.
Cancer Immunology, Immunotherapy : CII|March 2, 2024
Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinomaTanguy Y Seiwert, Sophie Wildsmith, Jérôme Fayette, et al.
International Journal of Radiation Oncology, Biology, Physics|October 14, 2015
Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral ImmunotherapyMiran Blanchard, Kevin G Shim, Michael P Grams, et al.
Head & Neck|January 11, 2016
Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trialsHisham Mehanna, Natalie Franklin, Natalie Compton, et al.
Pageof 20

Showing results (141-150 of 197) with videos related to

Sort By:
Pageof 20
British Journal of Cancer|November 25, 2016
Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neckLiam Welsh, Rafal Panek, Angela Riddell, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative diseaseKevin Harrington, Alain Berrier, Martin Robinson, et al.
Molecular Therapy Oncolytics|December 10, 2016
Immunogenicity of self tumor associated proteins is enhanced through protein truncationTim Kottke, Kevin G Shim, Vanesa Alonso-Camino, et al.
BMJ Open|August 9, 2024
Predicting radiotherapy response, Toxicities and quality-of-life related functional outcomes in soft tissue sarcoma of the extremities (PredicT) using dose-volume constraints development: a study protocolRita Simões, Sarah Gulliford, Beatrice Seddon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 16, 2016
The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with 18F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell CarcinomaKee H Wong, Rafal Panek, Liam Welsh, et al.
BMC Medical Research Methodology|July 11, 2022
Methodology for the development of National Multidisciplinary Management Recommendations using a multi-stage meta-consensus initiativeJohn C Hardman, Kevin Harrington, Tom Roques, et al.
Magma (New York, N.Y.)|January 5, 2011
A Bayesian hierarchical model for DCE-MRI to evaluate treatment response in a phase II study in advanced squamous cell carcinoma of the head and neckBrandon Whitcher, Volker J Schmid, David J Collins, et al.
Cancer Immunology, Immunotherapy : CII|March 2, 2024
Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinomaTanguy Y Seiwert, Sophie Wildsmith, Jérôme Fayette, et al.
International Journal of Radiation Oncology, Biology, Physics|October 14, 2015
Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral ImmunotherapyMiran Blanchard, Kevin G Shim, Michael P Grams, et al.
Head & Neck|January 11, 2016
Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trialsHisham Mehanna, Natalie Franklin, Natalie Compton, et al.
Pageof 20